Understanding The Unconventional Strategy That’s Driving Pulse Biosciences’ Recent Success

In this episode of DeviceTalks Weekly, Host Tom Salemi speaks with MedTech veteran Darrin Uecker about a career shaped by some of the industry’s most notable innovations and acquisitions. Uecker’s journey begins at Computer Motion, where he served as CTO through its historic acquisition by Intuitive Surgical. He recounts how that deal came together and traces the path that led him to senior leadership roles at multiple startups that ultimately achieved successful exits. Today, Uecker is chief technology officer at Pulse Biosciences, a small publicly traded company developing a next generation of pulsed-field ablation technology. He discusses the unconventional steps Pulse has taken to build its business, reviews the company’s latest clinical data, and shares his perspective on the future of the fast-moving PFA market. In our FOMO Interview, Ralph Kern, MD, chief medical officer of neuro startup Cognito Therapeutics, explains why he’s excited about technical advances in the field. He’s interviewed by Jim Hammerand, managing editor at Medical Design & Outsourcing magazine. As always we start the episode with MassDevice Editor Chris Newmarker and his top 5 stories of the week….aka Newmarker’s Newsmakers. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players +

You can listen to Understanding The Unconventional Strategy That’s Driving Pulse Biosciences’ Recent Success online on Radio and Podcast. Open the player on this page to stream the available audio.

Understanding The Unconventional Strategy That’s Driving Pulse Biosciences’ Recent Success is an episode from DeviceTalks by DeviceTalks.

This episode is 01:11:02 long.

This episode was published on Feb 13, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from DeviceTalks when more episodes are available from the podcast feed.